New CEO takes the reins at Wellcome Trust-DBT India Alliance

Dr Shahid Jameel has been appointed CEO of the India Alliance, an £80 million partnership between the Wellcome Trust and the Department of Biotechnology, Government of India.

Dr Jameel is Senior Scientist and Group Leader (Virology) at the International Centre for Genetic Engineering and Biotechnology, New Delhi, and brings more than 25 years of active biomedical research and laboratory management to the India Alliance.

Launched in 2008 and operated as a joint venture, the India Alliance aims to deliver a programme of research fellowship schemes to support current and future leaders of Indian biomedical science.

Commenting on his appointment in a statement on the India Alliance website, Dr Jameel said: "As we reach the halfway mark of our initial funding, we have the opportunity to build on a solid foundation and take the India Alliance higher – in the numbers of fellowships we fund, in continuing to attract the best talent, and in diversifying into new areas of biomedical research."

Dr Jameel announced that a new Committee will be in place this year to address the unique challenges of funding clinical and public health research in India. There are also plans to increase public engagement activities and serve larger numbers of young scientists through the Science and Communications Workshops.

Dr Jimmy Whitworth, one of the Trustees of the India Alliance and Head of International Activities at the Wellcome Trust, comments: "The success of agencies such as the India Alliance depends ultimately on the quality of their leadership. We have been extremely fortunate to have had Anuradha Lohia skilfully guiding the Alliance during its first four years, and we are confident that Shahid Jameel will be able to consolidate and build upon her success."